PuSH - Publication Server of Helmholtz Zentrum München

239 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Assfalg, R. et al.: Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial. Diabetologia 64, 1079-1092 (2021)
Bediaga, N.G.* et al.: Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample. Diabetologia, DOI: 10.1007/s00125-021-05523-2 (2021)
Gar, C. et al.: The liver–alpha cell axis associates with liver fat and insulin resistance: A validation study in women with non-steatotic liver fat levels. Diabetologia 64, 512-520 (2021)
Gastaldelli, A.* ; Stefan, N. & Häring, H.-U.: Liver-targeting drugs and their effect on blood glucose and hepatic lipids. Diabetologia, DOI: 10.1007/s00125-021-05442-2 (2021)
Gerst, F. et al.: The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells. Diabetologia 64, 1358–1374 (2021)
Giroud, M. et al.: HAND2 is a novel obesity-linked adipogenic transcription factor regulated by glucocorticoid signalling. Diabetologia, DOI: 10.1007/s00125-021-05470-y (2021)
Johnson, R.K.* et al.: Maternal food consumption during late pregnancy and offspring risk of islet autoimmunity and type 1 diabetes. Diabetologia, DOI: 10.1007/s00125-021-05446-y (2021)
Johnson, S.B.* et al.: First-appearing islet autoantibodies for type 1 diabetes in young children: Maternal life events during pregnancy and the child’s genetic risk. Diabetologia 64, 591-602 (2021)
Krischer, J.P.* et al.: Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study. Diabetologia, DOI: 10.1007/s00125-021-05514-3 (2021)
Morgenstern, J.* et al.: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia, DOI: 10.1007/s00125-021-05557-6 (2021)
Morgenstern, J.* et al.: Correction to: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia, DOI: 10.1007/s00125-021-05588-z (2021)
Pistrosch, F.* et al.: Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: A randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers. Diabetologia, DOI: 10.1007/s00125-021-05562-9 (2021)
Achenbach, P. et al.: Heterogeneous islet autoantibody evolution trajectories in multi-site birth cohort studies. Diabetologia 63, 1, S160-S160 (2020)
Anand, V.* et al.: Visualising heterogeneous islet autoantibody trajectories of children who develope type 1 diabetes from multi-site birth cohort studies. Diabetologia 63, 1, S101-S102 (2020)
Barovic, M. et al.: Exploring islet amyloidosis in type 2 diabetes in metabolically profiled pancreatectomised surgical donors. Diabetologia 63, 1, S163-S164 (2020)
Bauer, I. et al.: Maternal mental state correlates with maternal insulin sensitivity and interleukin-6 levels in late pregnancy. Diabetologia 63, 1, S211-S212 (2020)
Bovy, N.* et al.: Long-term follow-up study of type 1 diabetes patients previously treated with IMCY-0098 or placebo in young adults with recent-onset type 1 diabetes. Diabetologia 63, 1, S26-S27 (2020)
Brings, S.* ; Fleming, T.* ; Herzig, S. ; Nawroth, P.P.* & Kopf, S.*: Urinary cathepsin levels are predictive of the improvement of albuminuria and are associated with elevated excretion of free glucosepane. Diabetologia 63, 1, S384-S385 (2020)
Cobo-Vuilleumier, N.* et al.: Lrh1/nr5a2 conveys the anti-diabetic effects of the agonist bl001 and promotes alpha-to-beta-cell conversion in streptozotocin-treated mice. Diabetologia 63, 1, S182-S183 (2020)
De Luca, C.* et al.: Factors affecting function of human pancreatic islets after isolation. Diabetologia 63, 1, S179-S179 (2020)